The role of CnTI‐SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study
- 20 April 2007
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 29 (5) , 512-516
- https://doi.org/10.1002/uog.4013
Abstract
Objectives To describe sonographically the distribution patterns of a second‐generation contrast agent in the microcirculation of unilocular and multilocular ovarian masses with papillary projections, and to investigate whether qualitative evaluation of the passage of the contrast agent can improve the performance of sonography in distinguishing between benign and malignant masses with papillary projections. Methods Thirty‐three patients with unilocular or multilocular ovarian masses with papillary projections were enrolled into the study in three clinical centers. The contrast‐enhanced transvaginal examination was performed using ‘Contrast Tuned Imaging’ (CnTI) technology and SonoVue® ultrasound contrast agent. Results Twenty‐four (73%) lesions were benign, eight (24%) were borderline ovarian tumors, and one patient presented with an endometrioid ovarian adenocarcinoma. On color and power Doppler examinations the presence of vessels was demonstrated in 17 papillary projections, while on CnTI‐SonoVue examination, the presence of vessels was shown in these 17 and in six additional cases. In all cases with absent papillary perfusion after SonoVue intravenous injection, the cyst wall appeared unequivocally regular. The sensitivity and specificity of conventional color Doppler examination with regard to malignancy were 100% and 67% and the positive and negative likelihood ratios were 3.03 and 0.16, respectively. For the contrast‐enhanced examination the corresponding values were 100%, 42%, 1.7 and 0.26. The difference in specificity was statistically significant (P < 0.05) because 14 cases, in which papillary perfusion was detected after SonoVue injection, proved to be benign on pathological examination. Conclusion Qualitative evaluation of blood circulation in papillary projections using CnTI‐SonoVue examination does not improve the discrimination of benign from borderline/malignant ovarian masses with papillary projections. Copyright © 2007 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Ultrasound characteristics of different types of adnexal malignanciesGynecologic Oncology, 2006
- Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis?Ultrasound in Obstetrics & Gynecology, 2006
- Logistic Regression Model to Distinguish Between the Benign and Malignant Adnexal Mass Before Surgery: A Multicenter Study by the International Ovarian Tumor Analysis GroupJournal of Clinical Oncology, 2005
- Power Doppler vascularity index for predicting malignancy of adnexal massesUltrasound in Obstetrics & Gynecology, 2005
- Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.Journal of Ultrasound in Medicine, 2004
- Use of morphology to characterize and manage common adnexal massesBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Diagnostic Challenges in Patients With TumorsJournal of Clinical Oncology, 2003
- Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) groupUltrasound in Obstetrics & Gynecology, 2000
- Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal originEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
- Visualization of Blood Flow in Small Ovarian Tumor Vessels by Transvaginal Color Doppler Sonography after Echo Enhancement with Injection of Levovist®Gynecologic and Obstetric Investigation, 1994